Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human beta Catenin ELISA Kit (AC2936)
Cat.#: ASET-1525
Specifications
Description Human beta Catenin ELISA Kit allows for the in vitro quantitative determination of human beta Catenin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1931 Rat Aromatase ELISA Kit (AC3342) Quantitative inquiry ASET-1212 Horse Adiponectin ELISA Kit (AC2623) Quantitative inquiry ASET-1068 Mouse Wnt10b ELISA Kit (AC2479) Quantitative inquiry ASET-1216 Mouse VEGFC ELISA Kit (AC2627) Quantitative inquiry ASET-1908 Mouse NCAM1 ELISA Kit (AC3319) Quantitative inquiry ASET-1699 Human Wnt10b ELISA Kit (AC3110) Quantitative inquiry ASET-1134 Human NRXN3 ELISA Kit (AC2545) Quantitative inquiry ASET-2233 Human NMU ELISA Kit (AC3644) Quantitative inquiry ASET-1534 Human Apolipoprotein E ELISA Kit (AC2945) Quantitative inquiry ASET-1435 Monkey Heme Oxygenase 1 ELISA Kit (AC2846) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket